Why these ASX ETFs could be better than buying CBA shares

There's no denying the appeal of Commonwealth Bank of Australia (ASX: CBA) shares. It is one of the most widely held shares in the country, pays reliable dividends, and has long been seen as a cornerstone investment for Australian portfolios.

But popularity doesn't always equal superiority. At today's valuations, investors may want to consider whether a diversified ETF approach could offer a better balance of growth, income, and risk than owning CBA shares alone.

Here's why some ASX ETFs could stack up more favourably.

Valuation risks

CBA has often traded at a premium to its peers, and that premium reflects very high expectations. When a stock is priced for perfection, future returns can become constrained, even if the business continues to perform well.

ETFs, by contrast, spread valuation risk across dozens, or even hundreds, of stocks. For example, the Vanguard Australian Shares ETF (ASX: VAS) gives investors exposure to the entire local market, including banks, miners, healthcare leaders, and industrials. If one sector becomes overvalued, others can help offset that risk.

Rather than relying on a single bank to keep delivering, investors benefit from the broader earnings power of the Australian economy.

Better growth exposure outside banking

CBA is a mature business operating in a heavily regulated industry. While it can deliver steady profits, its long-term growth rate is naturally limited by credit growth, margins, and regulation.

ETFs such as the iShares S&P 500 ETF (ASX: IVV) provide exposure to some of the world's fastest-growing global companies, including Apple Inc (NASDAQ: AAPL), Microsoft Corp (NASDAQ: MSFT), and Nvidia Corp (NASDAQ: NVDA). Over time, global innovation, productivity gains, and technology adoption have driven stronger growth than most domestic banks can realistically achieve.

For investors focused on wealth creation rather than just stability, this broader growth exposure can be a meaningful advantage.

Quality option

Some investors buy CBA because they want quality and reliability. The good news is that ETFs can deliver this too. Importantly, that is without tying your fortunes to one company.

The VanEck Morningstar Wide Moat ETF (ASX: MOAT) focuses on businesses with sustainable competitive advantages and fair valuations. This is a concept closely aligned with Warren Buffett's investing philosophy.

Its holdings include stocks such as Adobe Inc (NASDAQ: ADBE), Nike Inc (NYSE: NKE), and Thermo Fisher Scientific Inc (NYSE: TMO), which benefit from strong brands, high switching costs, or scale advantages.

Instead of betting on one bank maintaining its dominance, investors gain access to a portfolio of global leaders with long-term pricing power.

The post Why these ASX ETFs could be better than buying CBA shares appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in Nike and VanEck Morningstar Wide Moat ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Adobe, Apple, Microsoft, Nike, Nvidia, Thermo Fisher Scientific, and iShares S&P 500 ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2026 $395 calls on Microsoft, long January 2028 $330 calls on Adobe, short January 2026 $405 calls on Microsoft, and short January 2028 $340 calls on Adobe. The Motley Fool Australia has recommended Adobe, Apple, Microsoft, Nike, Nvidia, VanEck Morningstar Wide Moat ETF, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025